Polyrizon
Company Details
Status: Private
Employees: 1-10
Location:
Raanana, Meẖoz HaMerkaz 4343306, IL
Type:
sample
sample
Technology:
sample
sample
About: We are a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form
of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses
and allergens from contacting the nasal epithelial tissue. Our proprietary Capture and Contain TM, or C&C, hydrogel technology, comprised
of a mixture of naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a “biological mask”
with a thin shield containment barrier in the nasal cavity. We are further developing certain aspects of our C&C hydrogel technology such
as the bioadhesion and prolonged retention at the nasal deposition site for intranasal delivery of drugs. We refer to our additional
technology, which is in an earlier stage of pre-clinical development, that is focused on nasal delivery of active pharmaceutical ingredients, or
APIs, as Trap and Target ™, or T&T.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Polyrizon | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.